PREMIUM = Requires Subscription. Learn More

Mail someone about this article


GlaxoSmithKline Tests RFID on HIV Drug

In a pilot project involving the HIV medication Trizivir, the company is testing its ability to commission and later read RFID tags, which could be used to verify the drug's authenticity.


Send to e-mail address:*



From e-mail address:*


Your comment to this article:



* Required fields


 << Back
SUBSCRIBE